Association between Low Plasma Phylloquinone Concentration and Warfarin Sensitivity in Japanese Patients
Abstract
Warfarin sensitivity exhibits marked interindividual variability, partly explained by genetic polymorphisms affecting vitamin K (VK) metabolism. However, the association between plasma VK concentrations and warfarin sensitivity remains unclear. We investigated this association in Japanese patients receiving warfarin therapy. Blood samples from patients aged ≥20 years were analyzed for genetic polymorphisms associated with warfarin sensitivity, warfarin concentrations, and plasma concentrations of phylloquinone (PK) and menaquinone-4 (MK4). The warfarin sensitivity index (WSI) was calculated as the change in prothrombin time-international normalized ratio per S-warfarin-equivalent concentration. Among 105 patients, plasma PK and MK4 concentrations were not significantly correlated with WSI when analyzed as continuous variables (p = 0.297 and p = 0.118, respectively). To determine whether plasma VK concentrations provided additional predictive information, WSI prediction models with and without VK variables were compared. Incorporating an indicator of plasma PK concentration <0.20 ng/mL improved model performance, whereas MK4-based models showed no clear improvement. In multivariable analysis, a plasma PK concentration <0.20 ng/mL was independently associated with a higher WSI after adjustment for established clinical and genetic factors (B = 0.703, 95% confidence interval, 0.057-1.349; p = 0.033). These findings suggest that a low plasma PK concentration may explain some of the interindividual variability in warfarin sensitivity beyond that accounted for by genetic polymorphisms. Direct measurement of plasma PK may provide additional information for understanding increased warfarin sensitivity in patients with low VK status.
Related
- Infectious disease communication for international students: A survey of association-accredited Japanese language schools in Japan
- Association between maternal dysglycaemia and adverse perinatal outcomes: A retrospective cohort study using a Japanese mother–infant-linked claims database
- Effect of coffee bean chlorogenic acid on peripheral skin temperature and skin blood flow in healthy Japanese women with cold sensitivity: a placebo-controlled, randomized, double-blind, study.
- Association Between Eosinophilic Chronic Rhinosinusitis and Bronchiectasis in a Japanese Cohort
- Association of medical visit frequency with cardiovascular events and mortality in patients with dyslipidaemia: a cohort study using a Japanese claims database.
BibTeX
@article{nagamine2026association,
title = {{Association between Low Plasma Phylloquinone Concentration and Warfarin Sensitivity in Japanese Patients}},
author = {Ayumu Nagamine and Hiromi Nishiba and Yuta Takahashi and Hideaki Yashima and Hironori Nakamura and Kaoru Uchida and Noriaki Takama and Norimichi Koitabashi and Tadashi Nakajima and Yoshiaki Ohyama and Tomoyuki Yokoyama and Kunihiko Imai and Noriaki Shimokawa and Masahiko Kurabayashi and Koujirou Yamamoto and Takuya Araki and Kyoko Obayashi},
journal = {Biological and Pharmaceutical Bulletin},
year = {2026},
month = oct,
doi = {10.1248/bpb.b26-00395},
url = {https://www.jstage.jst.go.jp/article/bpb/49/10/49_b26-00395/_article},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Association between Low Plasma Phylloquinone Concentration and Warfarin Sensitivity in Japanese Patients
AU - Ayumu Nagamine
AU - Hiromi Nishiba
AU - Yuta Takahashi
AU - Hideaki Yashima
AU - Hironori Nakamura
AU - Kaoru Uchida
AU - Noriaki Takama
AU - Norimichi Koitabashi
AU - Tadashi Nakajima
AU - Yoshiaki Ohyama
AU - Tomoyuki Yokoyama
AU - Kunihiko Imai
AU - Noriaki Shimokawa
AU - Masahiko Kurabayashi
AU - Koujirou Yamamoto
AU - Takuya Araki
AU - Kyoko Obayashi
PY - 2026
DA - 2026/10/16
JO - Biological and Pharmaceutical Bulletin
DO - 10.1248/bpb.b26-00395
UR - https://www.jstage.jst.go.jp/article/bpb/49/10/49_b26-00395/_article
AB - Warfarin sensitivity exhibits marked interindividual variability, partly explained by genetic polymorphisms affecting vitamin K (VK) metabolism. However, the association between plasma VK concentrations and warfarin sensitivity remains unclear. We investigated this association in Japanese patients receiving warfarin therapy. Blood samples from patients aged ≥20 years were analyzed for genetic polymorphisms associated with warfarin sensitivity, warfarin concentrations, and plasma concentrations of phylloquinone (PK) and menaquinone-4 (MK4). The warfarin sensitivity index (WSI) was calculated as the change in prothrombin time-international normalized ratio per S-warfarin-equivalent concentration. Among 105 patients, plasma PK and MK4 concentrations were not significantly correlated with WSI when analyzed as continuous variables (p = 0.297 and p = 0.118, respectively). To determine whether plasma VK concentrations provided additional predictive information, WSI prediction models with and without VK variables were compared. Incorporating an indicator of plasma PK concentration <0.20 ng/mL improved model performance, whereas MK4-based models showed no clear improvement. In multivariable analysis, a plasma PK concentration <0.20 ng/mL was independently associated with a higher WSI after adjustment for established clinical and genetic factors (B = 0.703, 95% confidence interval, 0.057-1.349; p = 0.033). These findings suggest that a low plasma PK concentration may explain some of the interindividual variability in warfarin sensitivity beyond that accounted for by genetic polymorphisms. Direct measurement of plasma PK may provide additional information for understanding increased warfarin sensitivity in patients with low VK status.
SN - 1347-5215
SN - 0918-6158
ER -